Wider use of MS drug Gilenya approved in Europ
Posted: Thu Jun 12, 2014 1:29 am
The European Commission has endorsed the recent Committee for Medicinal Products for Human Use (CHMP) positive opinion recommending the expanded use of Swiss drug major Novartis’ drug Gilenya (fingolimod) for adult patients with highly active relapsing-remitting multiple sclerosis (RRMS)..... Read More - http://www.ms-uk.org/gilenya